The problem of asymptomatic ventricular arrhythmias among survivors of acute myocardial infarction: Role of amiodarone

Maggioni, 1993, Prevalence prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results, Circulation, 87, 512, 10.1161/01.CIR.87.2.312 Teo, 1993, Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled clinical trials, JAMA, 270, 1589, 10.1001/jama.1993.03510130095038 Roden, 1993, Pharmacokinetics of amiodarone: implications for drug therapy, Am J Cardiol, 72, 45F, 10.1016/0002-9149(93)90962-C Cairns, 1991, Post-myocardial infarction mortality in patients with ventricular premature depolarizations: Canadian amiodarone myocardial infarction arrhythmia trial pilot study, Circulation, 84, 550, 10.1161/01.CIR.84.2.550 The CASCADE Investigators, 1993, Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE study), Am J Cardiol, 72, 280, 10.1016/0002-9149(93)90673-Z Weinberg, 1993, Five-year follow-up of 589 patients treated with amiodarone, Am Heart J, 125, 109, 10.1016/0002-8703(93)90063-F Burkart, 1990, Effect of antiarrhythmic therapy on mortality survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS), J Am Coll Cardiol, 16, 1711, 10.1016/0735-1097(90)90324-I Ceremuzynski, 1992, Effect of amiodarone on mortality after myocardial infarction: a double-blind placebocontrolled pilot study, J Am Coll Cardiol, 20, 1056, 10.1016/0735-1097(92)90357-S Cairns, 1993, Canadian amiodarone myocardial infarction arrhythmia trial (CAMIAT): rationale and protocol, Am J Cardiol, 72, 87F, 10.1016/0002-9149(93)90969-J Camm, 1993, The European myocardial infarct amiodarone trial (EMIAT), Am J Cardiol, 72, 95F, 10.1016/0002-9149(93)90970-N